1-7 of 7
Sandra Acholonu
Close
Sort by
Journal Articles

Donor Leukocyte Infusions (DLIs) for Recurrent Hodgkin Lymphoma (HL) Following Allogeneic Stem Cell Transplantation (allo-SCT): Ten-Year Experience at the M.D. Anderson Cancer Center

Paolo Anderlini, MD, Sandra Acholonu, Grace-Julia Okoroji, Sergio A Giralt, MD, Roy Jones, MD, PhD, Chitra M Hosing, MD, Muzaffar H Qazilbash, MD, Yago Nieto, MD, PhD, Borje S Andersson, MD, PhD, Uday R Popat, MD, Naoto T Ueno, MD, Marcos J de Lima, MD, Richard E Champlin, MD
Journal: Blood
Blood (2011) 118 (21): 4460.
https://doi.org/10.1182/blood.V118.21.4460.4460
Published: 2011
Journal Articles

Gemcitabine, Fludarabine, and Melphalan (G-FM) as Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Stem Cell Transplantation (Allo-SCT) in Relapsed and Refractory Hodgkin Lymphoma (HL)

Paolo Anderlini, MD, Rima M Saliba, PhD, Celina Ledesma, B.S., Christina M Chancoco, Sandra Acholonu, Rosamar Valverde, Uday R Popat, MD, Chitra M Hosing, MD, Amin M Alousi, MD, Elizabeth J Shpall, MD, Yago Nieto, MD, PhD, Stefan O Ciurea, MD, Issa Khouri, MD, Richard Champlin, MD
Journal: Blood
Blood (2011) 118 (21): 3003.
https://doi.org/10.1182/blood.V118.21.3003.3003
Published: 2011
Journal Articles

Prognostic Factors after Nonmyeloablative Allogeneic Stem Transplantation (NST) in Chronic Lymphocytic Leukemia (CLL): Expression of P53 May Not Predict Survival.

Issa Khouri, Roland L Bassett, Yvonne Hsu, Timothy Dickason, Sandra Acholonu, Robyn Harrell, Grace-Julia Okoroji, Leandro de Padua Silva, Martin J. Korbling, Amin M. Alousi, Chitra Hosing, Uday Popat, Sergio A. Giralt, Partow Kebriaei, Muzaffar H. Qazilbash, M.D., Celina Ledesma, Michael J. Keating, MB, BS, Richard E. Champlin, Carlos Bueso-Ramos
Journal: Blood
Blood (2008) 112 (11): 1128.
https://doi.org/10.1182/blood.V112.11.1128.1128
Published: 2008
Journal Articles

Two-Year Follow-Up Results at the M.D. Anderson Hospital with Reduced-Intensity Allogeneic Stem Cell Transplantation with Fludarabine-Melphalan as Preparative Regimen in Relapsed/Refractory Hodgkin’s Lymphoma: Comparable Outcome with Matched Related and Unrelated Donors.

Paolo Anderlini, Rima M. Saliba, Sandra Acholonu, Sergio A. Giralt, Issa F. Khouri, Borje Andersson, Marcos De Lima, Chitra Hosing, Daniel Couriel, Richard E. Champlin
Journal: Blood
Blood (2006) 108 (11): 3115.
https://doi.org/10.1182/blood.V108.11.3115.3115
Published: 2006
Journal Articles

Reduced-Intensity Conditioning Regimen with BEAM/Rituximab for Patients with Refractory Non-Hodgkin’s Lymphomas.

Issa F. Khouri, MD, Rima M. Saliba, MD, Grace-Julia Okoroji, Sandra Acholonu, Farzaneh Maadani, Chitra Hosing, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2004) 104 (11): 2315.
https://doi.org/10.1182/blood.V104.11.2315.2315
Published: 2004
Journal Articles

Effect of High-Dose Rituximab on Peripheral Blood Stem Cell Mobilization in Intermediate Grade Non-Hodgkin’s Lymphomas.

Chitra Hosing, MD, Rima M. Saliba, PHD, Martin Korbling, MD, Sandra Acholonu, Safa Karandish, Sergio Giralt, MD, Jo Lauppe, Marcos de Lima, MD, Grace-Julia Okoroji, Daniel R. Couriel, MD, Richard Champlin, MD, Issa F. Khouri, MD, Michele L. Donato, MD
Journal: Blood
Blood (2004) 104 (11): 2877.
https://doi.org/10.1182/blood.V104.11.2877.2877
Published: 2004
Journal Articles

Effect of Rituximab on the Incidence of GVHD in Lymphoma Patients who Received the BEAM-Conditioning and an Allogeneic Stem Cell Transplantation.

Issa F. Khouri, MD, Rima M. Saliba, PhD, Daniel R. Couriel, MD, Grace-Julia Okoroji, Sandra Acholonu, Farzaneh Maadani, Richard E. Champlin, MD
Journal: Blood
Blood (2004) 104 (11): 4980.
https://doi.org/10.1182/blood.V104.11.4980.4980
Published: 2004